Matt Link

Matthew Link joined HealthpointCapital in November 2025.  He brings over 20 years of experience building teams and leading innovation in the healthcare and medical technology industries, most
recently serving as Chief Commercial Officer at Sight Sciences, an eyecare technology company focused on developing and commercializing innovative interventional technology intended to treat disease in the anterior segment of the eye. Prior to Sight Sciences, Matt spent nearly 15 years in regional and executive leadership positions at NuVasive, Inc., a global leader in surgical implants and enabling technology for spine surgery and orthopedics.  Matt joined NuVasive as an Area Business Manager and rose to the level of President where his responsibilities included oversight of global business units in spine, neurophysiology and orthopedics. Prior to NuVasive, he held commercial leadership roles at Depuy Orthopedics and Depuy Spine. He currently serves as a member of the board of directors of Springbok Analytics and Fibrobiologics, and previously served on the oversight board of the Coulter Translational Research Endowment at the University of Virginia. Matt received a BSEd in Physical Education and Sports Medicine from the University of Virginia.